AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2015

May 1, 2015

5229_dirs_2015-05-01_7a8c3cfe-7369-4300-93da-02f1e7c60f7b.html

Director's Dealing

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0449M

AstraZeneca PLC

01 May 2015

Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

The following individuals, who are all Directors of the Company, have notified us that they have purchased AstraZeneca PLC Ordinary Shares of $0.25 each or AstraZeneca American Depositary Shares (ADSs).

One AstraZeneca ADS equals one AstraZeneca PLC Ordinary Share of $0.25.


Name of Director	Date of notification	Date of purchase	Number of shares purchased	Purchase price
Cori Bargmann	1 May 2015	29 April 2015	700	$69.21
Ann Cairns	1 May 2015	30 April 2015	1,100	4455p
Jean-Philippe Courtois	29 April 2015	28 April 2015	2,500	4536p

A C N Kemp

Company Secretary

1 May 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUAOURVWAVRAR